Effects of Ocular Angiography on Intraocular Pressure in Diabetic Patients

Not Applicable

Completed

• Conditions: on - proliferative diabetic retinopathy; Non - proliferative diabetic retinopathy; Eye - Diseases / disorders of the eye; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12613000433707
• Lead Sponsor: Gokhan Pekel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Non-proliferative diabetic retinopathy patients

Exclusion Criteria

Having any ocular disease other than non - proliferative diabetic retinopathy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intraocular pressure<br>Intraocular pressure (IOP) measurements were done with the Pascal dynamic contour tonometer (Pascal DCT, Swiss Microtechnology AG, Port, Switzerland). This is a slit-lamp biomicroscopy mounted, self-calibrating, 7-mm tip diameter, and 1.2-mm pressure sensor diameter device.[5 minutes after intravenous fluorescein dye injection];Ocular pulse amplitude<br>Ocular pulse amplitude measurements were done with the Pascal dynamic contour tonometer (Pascal DCT, Swiss Microtechnology AG, Port, Switzerland).[5 minutes after intravenous fluorescein dye injection]

Secondary Outcome Measures

Name	Time	Method
intraocular pressure gender difference<br>This outcome was assessed by Pascal dynamic contour tonometer.[5 minutes after intravenous fluorescein dye injection];ocular pulse amplitude gender difference<br>This outcome was assessed by Pascal dynamic contour tonometer.[5 minutes after intravenous fluorescein dye injection]